Mutational analysis of class III receptor tyrosine kinases (C-KIT, C-FMS, FLT3) in idiopathic myelofibrosis (Q34176633)

31 July 2017

title

Mutational analysis of class III receptor tyrosine kinases (C-KIT, C-FMS, FLT3) in idiopathic myelofibrosis (English)

1 reference

31 July 2017

1 reference

Anne C Goodeve

2

0 references

author name string

Faisel M Abu-Duhier

1

1 reference

31 July 2017

Rory S Care

3

1 reference

31 July 2017

Mamdooh Gari

4

1 reference

31 July 2017

Gill A Wilson

5

1 reference

31 July 2017

Ian R Peake

6

1 reference

31 July 2017

John T Reilly

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

British Journal of Haematology

31 July 2017

published in

1 reference

31 July 2017

volume

120

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

464-470

1 reference

Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04108.X

Sequence analysis of two genomic regions containing the KIT and the FMS receptor tyrosine kinase genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04108.X

A rapid method for haemophilia B mutation detection using conformation sensitive gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04108.X

c-kit Point mutation in patients with myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04108.X

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04108.X

Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04108.X

Class III receptor tyrosine kinases: role in leukaemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04108.X

Single-nucleotide polymorphisms can cause different structural folds of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04108.X

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04108.X

Oncogenic activation of the alphaPDGFR defines a domain that negatively regulates receptor dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04108.X

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04108.X

Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04108.X

10.1046/J.1365-2141.2003.04108.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference